home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Antibody World Summit

 
  June 21, 2007  
     
 
ALM's Strategic Research Institute, Hyatt Regency New Brunswick
July 16- 17, 2007


The Antibody World Summit (AWS) is among the industry's largest annual gatherings of senior-level executives and decision-makers from the world's pharmaceutical, biotechnology companies and the service provider community. The conference is multi-tracked to provide concurrent coverage of the many topics encompassed within its broad framework. Attendees may, at any time during the AWS, sit in on any of the multiple sessions. This feature provides unparalleled options for the attendee and opportunity to customize one's participation. In sum, the annual AWS is perhaps the finest information and networking event for the antibody R&D executives to access vital new information and meet new clients.
 
 
Organized by: SRI
Invited Speakers: Uwe Gottschalk
Vice President, Purification Technologies
Sartorius AG

John Marrow
President
Newport Biotechnology Consultants

David J. King, Sr.
Director, Molecular Biology & Biochemistry
Medarex Inc

Linda Pullan
Consultant/Business Development
Pullan Consulting

Leland Webster
Executive Director, Business Development
ImmunoGen, Inc.

Kinney Horn
Manager, Business Development
Genentech

Trevor Collingwood
Team Leader, Enabling Technologies
Sangamo BioSciences

KC Cheng
Associate Director of Analytical & Formulation Development
Medarex

John Desjarlais
Department of Computational Biology
Xencor

Jim Mo, Ph.D.
Research Fellow, Pharmaceutical Sciences, Biologics
Pfizer Global Research & Development

John Weidanz
Chief Scientist (Professor, Texas Tech Health Sciences Center School)
Texas Tech University

Curtis Meuse
Biochemical Sciences Division
National Institute of Standards and Technology

Dimiter Dimitrov, Ph.D. Sc.D
Senior Investigator, Protein Interactions, Center for Cancer Research Nanobiology Program
NIH

Stephanie Finnegan
CEO
Goodwin Biotechnology, Inc.

Sean Stevens, Ph.D.
Associate Director of Immunology
Regeneron Pharmaceuticals, Inc

Yong Jick Kim
SVP, Manifacturing & Technology Division
Celltrion, Inc.

Rajeeva Singh
Director, Biochemistry
Immunogen, Inc

Paul W. Guptill, M.S.
Senior Director, Manufacturing Services
Medarex, Inc.

Gilles Gallant
Vice-President, Clinical Oncology
Human Genome Sciences

Brian Baynes
Chief Scientific Officer and Founder
Condon Devices

Steve Coats
Director of Oncology Research
Medimmune

Hung Wei Chih
Scientist
Genentech

Alexey Lugovskoy, Ph.D.
Head, Molecular Modeling
Biogen Idec

Balazs Hunek
Seniro Manager, Technology
Praxair

Brian Cao
Scientific Investigator
Van Andel Research Institute

Joe Zhou, Ph.D.
Scientific Director, Purification Process Department
Amgen, Inc.

Gail Sofer
Director, Regulatory Compliance
GE Healthcare

Ryan M. Doxey
Scientist II, Methiod Development
Steifel Research Institute

Ryan O'Neal, Sr.
Research Scientist I
Steifel Research Institute

Lynn Macdonald
Associate Director Pain Therapeutics & Genomic Technology Development
Regeneron Pharmaceuticals

Ben Roman
Associate Scientist
Amgen Inc


 
Deadline for Abstracts: none
 
Registration: Standard Rate: $1295 until Friday, June 29, 2007; $1695 thereafter (Registration for this meeting provides access to both AWS tracks) Full Time Academics/University: $795 (subject to approval) http://www.srinstitute.com/aws or 212-967-0095
E-mail: kstewart@srinstitute.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.